Diverse human aldolase C gene promoter regions are required to direct specific LacZ expression in the hippocampus and Purkinje cells of transgenic mice  by Buono, Pasqualina et al.
FEBS 29068 FEBS Letters 578 (2004) 337–344Diverse human aldolase C gene promoter regions are required to
direct speciﬁc LacZ expression in the hippocampus and Purkinje cells
of transgenic mice
Pasqualina Buonoa,b,c, Ottavia Barbierid,f, Andreina Alﬁerib,c, Annamaria Rosicae,
Simonetta Astigianof, Daniela Cantatored, Annamaria Mancinib,c, Olimpia Fattorusob,c,
Francesco Salvatoreb,c,*
a Facolta` di Scienze Motorie, Universita` ‘‘Parthenope’’, Naples, Italy
b Dipartimento di Biochimica e Biotecnologie Mediche, Universita` di Napoli ‘‘Federico II’’, Naples, Italy
c CEINGE–Biotecnologie avanzate, Naples, Italy
d Dipartimento di Oncologia, Biologia e Genetica, Universita` di Genova, Genoa, Italy
e Stazione Zoologica A. Dohrn, Naples, Italy
f Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Received 8 November 2004; accepted 10 November 2004
Available online 24 November 2004
Edited by Jesus AvilaAbstract Aldolase C is selectively expressed in the hippocam-
pus and Purkinje cells in adult mammalian brain. The gene pro-
moter regions governing cell-speciﬁc aldolase C expression are
obscure. We show that aldolase C messenger expression in the
hippocampus is restricted to CA3 neurons. The human distal pro-
moter region (200/1200 bp) is essential for b-galactosidase
(b-gal) expression in CA3 neurons and drives high stripe-like
b-gal expression in Purkinje cells. The 200 bp proximal promoter
region is suﬃcient to drive low brain-speciﬁc and stripe-like b-gal
expression in Purkinje cells. Thus, the human aldolase C gene se-
quences studied drive endogenous-like expression in the brain.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The aldolase C gene encodes the brain-speciﬁc form of the
glycolytic enzyme. The kinetic properties of the aldolase C en-
zyme, tested against the two major substrates fructose-1-phos-
phate and fructose-1,6-bisphosphate, are intermediate with
respect to the A and B isoforms [1]. The gene is transcribed
exclusively in the central nervous system (CNS), i.e., in the hip-
pocampal neurons and in the Purkinje cells of the cerebellum
[2–5]. Like other brain-speciﬁc genes, the aldolase C gene is en-
dowed with properties characteristic of housekeeping genes: it
lacks a normal TATA box, and a GC-rich region is present just
upstream from the major transcriptional start site. Further-
more, a CAAT box is located much further upstream than ex-
pected [6–8]. Several tissue-speciﬁc methylation sites have been
found around the transcription unit in the rat gene [9]. Aldol-Abbreviations: CNS, central nervous system; b-gal, b-galactosidase
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in vitro models. The proximal region of the rat promoter,
spanning about 115 bp upstream from the major transcrip-
tional start site, is able to direct CAT-reporter gene expression,
albeit at low levels, in the brain of transgenic mice [10–12]. The
upstream region binds Pax-6 transcriptional factor and is in-
volved in the activation of rat aldolase C gene expression in
the brain of transgenic mice [13]. We previously showed, in hu-
man-derived neuronal cells (SKNBE), that two regions (prox-
imal and distal) are required for the complete transcriptional
expression of the CAT-reporter gene of chimeric aldolase C
[14]. We also characterized in the distal region a functional
binding-site (element D) for the transcriptional activator
NGFI-B. The binding of NGFI-B to element D increases tran-
scription of the CAT-reporter gene in neuronal cell lines and
mediates cAMP induced transcriptional activation of a chime-
ric aldolase C CAT gene in PC12 cells [15,16]. A peculiar cyto-
histological aldolase C pattern has been demonstrated in the
mouse and rat cerebellum, where the zebrin II protein was
identiﬁed as aldolase C [17,18]. Recently, we identiﬁed that
pattern in the human brain [5].
In the present study, we compared the expression of endog-
enous aldolase C mRNA in adult mouse hippocampus and cer-
ebellum to that of LacZ expression driven by diverse human
aldolase C gene promoter regions. We found that the complete
human promoter region (1200 bp) drives high LacZ expression
in CA3 hippocampal neurons and its stripe-like expression in
Purkinje cells of transgenic mice, thereby mimicking endoge-
nous aldolase C expression. The 200-bp construct lacking the
distal promoter region failed to direct LacZ expression in
CA3 hippocampal neurons and conserved only the low
stripe-like LacZ expression in Purkinje cells.2. Materials and methods
2.1. Cloning and DNA preparation for microinjection
The transgenic construct (pAldC2500-LacZ) was obtained by clon-
ing in the SalI/BamHI sites of the pBluescript SK+ vector (Stratagene)
the human aldolase C promoter region up to the methionine residue in
exon 2 (2500 bp) [19] that was fused in-frame with the methionineation of European Biochemical Societies.
338 P. Buono et al. / FEBS Letters 578 (2004) 337–344residue of the bacterial LacZ cassette [20]. The mouse b-globin
poly(A)+ cassette (1500 bp) [21] was subcloned downstream from the
LacZ cassette (see Figs. 1A and B). The Quick Change site-directed
mutagenesis kit (Stratagene) was used to create pAldC2500*-LacZ
lacking element D (Fig. 1B) and pAldC1500-LacZ containing only
36 bp of the distal region and element D (Fig. 1B). Recombinant mu-
tated plasmids were puriﬁed over a Qiagen column and their sequences
were veriﬁed by automated sequencing. After removal of vector se-
quences by Sal/NotI digestion, the microinjection fragments were puri-
ﬁed from agarose gel by electroelution and phenol:chloroform
extraction, resuspended in TE buﬀer at 2 ng/ll and microinjected into
1-cell fertilized eggs.
2.2. Generation and identiﬁcation of transgenic mice
Single-cell embryos were harvested from the hybrid B6D2F1 mouse
strain (Charles River). The puriﬁed Ald C/LacZ fragments were micr-
oinjected into the embryonic male pronuclei and surviving embryos
were transferred into the oviducts of pseudopregnant CD-1 foster
mothers (Charles River) essentially as described in Hogan et al. [22].
Transgenic founders and oﬀspring were identiﬁed by Southern blot
using a [a32-P]ATP random-primed LacZ cDNA probe. Three mouse
lines were obtained using the pAldC2500-LacZ construct; eight inde-
pendent transgenic founders were obtained with pAldC2500*-LacZ
and with pAldC1500-LacZ (see Fig. 1B). The Animal Experimentation
Ethics Committee of the National Institute for Cancer Research of
Genoa approved all the animal studies.
2.3. b-Galactosidase assay
b-Galactosidase (b-gal) activity was assayed in intact brains and
body parts of adult transgenic mice obtained from the three constructs;
coronal plate sections were identiﬁed according to Altman and Bayer
[23]. After ﬁxation in 2% paraformaldehyde for 1 h, the organs were
rinsed and incubated overnight at 30 C in phosphate-buﬀered saline
(PBS) containing 400 lg/ml X-Gal substrate (5-bromo-4-chloro-3-
indolyl-b-D-galactoside), 4 mM potassium ferricyanide, 4 mM MgCl2,
and 0.1% Nonidet P-40 as described in Smeyne et al. [24] and in Ober-Fig. 1. Structure of the human aldolase C gene promoter and human trans
major transcription start site. cis-acting elements in the proximal region (A, B
bar) is element D [15]; the transcription factor-binding sites in the distal r
rectangles represent the proximal promoter region that is conserved (more th
the empty rectangles represent exons 1 and 2 up to the AUG; the intron 1 is in
1200 bp of the human promoter region with the proximal and the distal regio
in exon 2. The LacZ cassette is indicated by the dotted box; the poly(A)+
construct pAldC2500*-LacZ is identical to the pAldC2500-LacZ construct b
proximal promoter region and only 36 bp of the distal region including elemen
the stabilized transgenic mouse lines obtained from the pAldC2500-LacZ c
transgenic founders obtained using the pAldC2500*-LacZ construct; D-01
founders obtained using construct pAldC1500-LacZ. Restriction sites: B = B
was no correlation between copy number and b-gal activity.dick et al. [25]. Cryostat sections from adult transgenic mice were ob-
tained as described in Oberdick et al. [25]. After b-gal assay, the brains
were equilibrated with 30% sucrose overnight, embedded in OCT com-
pound (VWR), cut into 10-lm serial sections on a cryostat or in 200-
lm sections on a vibratome and collected on coated glass slides
(VWR).2.4. Northern blot analysis
Total RNA was isolated from mouse adult brain, liver, kidney and
heart using the CsCl method [26]. For the Northern blot procedure, we
used 20 lg of total RNA as previously described [15]. A 1600-bp
BamHI fragment from the human glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) cDNA [27], a 3100-bp fragment containing the
coding region for bacterial b-gal [20] and a 560-bp fragment containing
the 3 0-region of mouse cDNA speciﬁc for the aldolase C isoform [7]
(i.e., the same probes used in in situ hybridization) served as probes.
The fragments were labelled according to a random priming kit proce-
dure (Takara). Endogenous aldolase C messenger expression and het-
erologous aldolase C-b-gal expression were determined by Phosphor
Imager membrane analysis (Storm 840, Molecular Dynamics, Amer-
sham Biosciences). The relative abundance, normalized for GAPDH
expression, was calculated using the Image Quant v 1.1 software and
is expressed as the mean values of two experiments.2.5. In situ hybridization
Animals were killed by cervical dislocation; brains were removed,
washed in PBS and ﬁxed in phosphate-buﬀered 4% paraformaldehyde.
The brains were then embedded in paraﬃn, cut in 7-lmmicrotome sec-
tions and collected on coated glass slides. To generate RNA probes
with which to detect the endogenous messenger a 560-bp PstI fragment
of the 3 0-mouse aldolase C cDNA [7] was subcloned in the PstI site in
the pBluescript KS+ vector. Sense and antisense cRNA probes were
generated using T3 and T7 RNA polymerases in the presence of digox-
igenin-11-UTP (Roche). In situ hybridization was essentially as de-
scribed in Boehm et al. [28].genic constructs. (A) Human aldolase C promoter structure. +1 is the
and C) are shown. The black rectangle in the distal region (heavy black
egion (GC-rich, AT-rich and CAAT motif) are circled. The hatched
an 75% homology) among the mouse, rat and human genes [11,14,15];
dicated by (a). (B) The transgenic construct pAldC2500-LacZ contains
n including element D, exon 1 and intron 1, up to the methionine (Met)
cassette is indicated by a rectangle with vertical lines; the transgenic
ut lacks element D; transgenic construct pAldC1500-LacZ contains the
t D. E-18 is the not stabilized transgenic mouse line, B-05 and B-18 are
onstruct; C-05, C-13, C-18, C-26, C-30, C-35, C-38 and C-40 are the
, D-03, D-13, D-25, D-30, D-37, D-40 and D-42 are the transgenic
amHI, N = NotI, S = SalI. 1Copy numbers ranged from 5 to 24. There
P. Buono et al. / FEBS Letters 578 (2004) 337–344 3392.6. Immunohistochemistry
Paraﬃn sections from brain were rinsed in PBS with 0.2% Triton X-
100 (PBST) and incubated 14 h at 4 C with anti-calbindin (Swant),
anti-glial ﬁbrillary acidic protein (GFAP) and with anti-b-gal poly-
clonal antibodies (Chemicon) in 1.5% goat serum in PBST. The sec-
tions were then rinsed and incubated for 1 h in biotinylated
secondary antibody. Immunocomplexes were visualized with an ABC
Elite kit and the 3,3 0-diaminobenzidine method (Vector Laboratories).
Diﬀerent developing times were used for the two constructs: 15–20 s
for pAldC2500-LacZ and pAldC2500*-LacZ and 50 s for
pAldC1500-LacZ.3. Results
3.1. Brain-speciﬁc expression of the fusion human gene in
transgenic mice
To investigate the promoter region(s) of the human aldolase
C gene involved in its brain-speciﬁc expression, we produced
transgenic mice with three diﬀerent constructs (Figs. 1A and
B). Plasmid pAldC2500-LacZ containing the complete pro-
moter region of the human gene (1200 bp), plasmid
pAldC2500*-LacZ carrying deletion (10 bp) of distal element
D (Fig. 1B, second line), and plasmid pAldC1500-LacZ carry-
ing the proximal region (164 bp) plus 36 bp of the distal region,
and intact element D (Fig. 1B, third line) were microinjected in
embryonic male pronuclei to generate transgenic founders. We
obtained three pAldC2500-LacZ mouse lines (E18, B-05 and
B-18), two of which (B-05 and B-18) were established. Eight
independent transgenic founders were obtained from plasmids
pAldC2500*-LacZ and pAldC1500-LacZ, (Fig. 1B). Brains
from three B-05 and three B-18 adult animals and from three
founders (C-05, C-13 and C-18) obtained with pAldC2500*-Fig. 2. b-gal activity in whole-mount brain and in cryo-sections brain from
mouse brain obtained with the pAldC1500-LacZ construct; note the absence
brain. (C) b-gal whole-mount activity of a mouse brain from the B-18 line;
hemispheres (h) and midbrain (mid); staining is highest in the cerebellum (cb).
taken at the coronal plate 25 [23] in which b-gal activity is strong in the ce
Coronal cryostat section of the same brain shown in (C) with b-gal activity re
the images are magniﬁed 5 times with respect to the slides. Scale bars: (D) 1LacZ and three founders (D-01, D-03 and D-13) obtained with
pAldC1500-LacZ were dissected from the bodies, and both
brains and bodies were examined for b-gal activity in a
whole-mount experiment. No b-gal activity was detected in
the three brains from the transgenic founders D-01, D-03
and D-13 (Fig. 2A). b-gal activity was detected only in the
brains of B-05 and B-18 mice and of pAldC2500*-LacZ foun-
ders (Fig. 2C). Activity was similar in the brains of these mice;
it was highest in the cerebellum, and low in the midbrain and
in the brain hemispheres (Fig. 2C, cb, mid and h, respectively).
A coronal vibratome section of plate 25 [23] from a B-18 trans-
genic mouse shows in greater detail the intense b-gal activity in
the cerebellum (Fig. 2D, cb) and the low activity in the pons
and medulla (Fig. 2D, po and m). A coronal cryostat section
from the same transgenic mouse cerebellum shows b-gal activ-
ity in clusters of Purkinje cells alternating with clusters of b-
gal-negative Purkinje cells (Fig. 2E), thereby resulting in the
characteristic zebrin-like distribution described for the rat
endogenous aldolase C mRNA [17]. Apart from brain, no b-
gal activity was found in any organ (not shown).
We next measured endogenous aldolase C mRNA expres-
sion in the brain, liver, kidney and heart of two B-18 mice,
two pAldC2500*(C-26 and C-30) and two pAldC1500-LacZ
founders (D-25 and D-30) in a Northern blot experiment.
Endogenous aldolase C mRNA expression occurred only in
brains (Fig. 3, dotted bar). Similarly, b-gal expression was de-
tected only in the brains of the two pAldC2500-LacZ,
pAldC2500*-LacZ and pAldC1500-LacZ mice brains exam-
ined (Fig. 3, white and black bars). This experiment conﬁrms
that b-gal expression is restricted to the brain and that it coin-
cides with the expression of the endogenous messenger. Thetransgenic mice. (A) b-gal whole-mount staining of D-03 transgenic
of b-gal activity. (B) Whole-mount staining of non-transgenic mouse
b-gal expression is scattered, more or less sparsely, over the cerebral
(D) Coronal vibratome brain section from the same brain shown in (C)
rebellum (cb), and much lower in the pons (po) and medulla (m). (E)
stricted to clusters of Purkinje cells within the cerebellum cortex. (A–C)
000 lm; (E) 500 lm.
Fig. 3. Phosphor Imager results of Northern blot experiments with
aldolase C and aldolase-C-LacZ mRNA expression in diﬀerent tissues
of transgenic mice. Total RNA from brain, liver, kidney and heart
obtained from two B-18 transgenic mice and from two pAldC2500*-
LacZ founders (C-26 and C-30) and two pAldC1500-LacZ founders
(D-25 and D-30) was analyzed. The dotted bar shows endogenous
aldolase C mRNA expression, the white bar shows messenger aldolase
C-b-gal expression obtained with the pAldC2500-LacZ and
pAldC2500*-LacZ constructs; the black bar shows messenger aldolase
C-b-gal expression obtained with the pAldC1500-LacZ construct. The
values represent means ± S.D. of two experiments.
Fig. 4. In situ hybridization and anti-b-gal immunostaining on sagittal h
hybridization with speciﬁc mouse aldolase C antisense riboprobe shows spe
neurons in the hippocampus. (B) b-gal immunostaining of sagittal hippocamp
same CA3 neuronal cells that express the endogenous messenger. (C–F
immunostaining on a hippocampal section obtained from a D-40 transgenic f
is evident in CA3 neuronal cells even at the higher magniﬁcation shown
subregions. Scale bars: (A, B, G) 1000 lm; (C, H) 500 lm; (D) 200 lm; (E,
340 P. Buono et al. / FEBS Letters 578 (2004) 337–344b-gal expression in the brains of animals carrying the complete
promoter sequence (pAldC2500-LacZ) or deletion of element
D (pAldC2500*-LacZ) (Fig. 3, white bar) was as high as
endogenous aldolase C mRNA expression, whereas it was
about 50% lower in animals carrying the large deletion in the
distal promoter (pAldC1500-LacZ, Fig. 3, black bar). This re-
sult indicates that 200 bp of the human promoter region (164
bp of the proximal region plus 36 bp of the distal region) is suf-
ﬁcient to induce brain-speciﬁc b-gal expression, conﬁrming the
results of in vitro experiments [14,15]. The apparent discrep-
ancy between undetectable b-gal activity in whole mount
pAldC1500-LacZ brains and the presence of b-gal-AldC hy-
brid mRNA in the brains of mice carrying the same construct
can be ascribed to the greater sensitivity of the Northern blot
method versus the histochemical procedure. However, the
function of element D, which induces CAT reporter gene tran-
scription 2.5-fold compared with the 164 bp construct in hu-
man neuroblastoma cells [15], seems to be exerted also by
other elements present in the distal promoter region.3.2. Diﬀerential expression of aldolase C-LacZ transgene in
the hippocampus and cerebellum
To investigate the distribution of endogenous aldolase C
mRNA within hippocampus and cerebellum we used a mouse
aldolase C-speciﬁc antisense riboprobe to hybridize sagittal
paraﬃn sections of adult transgenic mouse brain. Within the
hippocampus, aldolase C was expressed only in the pyramidal
neurons of hippocampus region CA3 (Fig. 4A). A sense strandippocampal paraﬃn sections of adult transgenic mice. (A) In situ
ciﬁc endogenous aldolase C mRNA expression restricted to the CA3
al sections from B-18 transgenic mice: speciﬁc labeling is evident in the
) Magniﬁcations of the boxed area indicated in (B). (G–I) b-gal
ounder obtained using pAldC1500-LacZ construct: no immunostaining
in (H) and (I). DG = dentate gyrus, CA1 and CA3 = hippocampal
I) 100 lm; (F) 50 lm.
Fig. 5. In situ hybridization and b-gal immunostaining on paraﬃn
sagittal cerebellar sections from transgenic mice. (A) In situ hybrid-
ization using mouse speciﬁc aldolase C antisense riboprobe: note the
intense expression of the endogenous messenger throughout the
Purkinje cell layer; aldolase C is localized in the perikaryon of
Purkinje cells. (B) The boxed area in (A) at a higher magniﬁcation.
(C) Anti-b-gal immunostaining on sections of B-18 transgenic mice: b-
gal expression is evident in groups of Purkinje cells surrounded by
negative Purkinje cells. (D and E) Part of the boxed area indicated in C
is shown at a higher magniﬁcation in D and E: two positive Purkinje
cells (thick arrows) surrounded by negative Purkinje cells (thin arrows)
are indicated. (F) Anti-b-gal immunostaining on sections from a
transgenic D-40 founder mouse: note the same b-gal expression pattern
throughout the Purkinje cells as observed in the B-18 transgenic
mouse; (G) part of the boxed area indicated in F is reported at a higher
magniﬁcation. Note the clusters of Purkinje cells expressing b-gal
(thick arrows) alternating with clusters of b-gal-negative Purkinje cells
(thin arrows). (H) Anti-calbindin immunohistochemistry. Staining
throughout the Purkinje cell layer shows the integrity of this layer; note
the localization in the perikaryon of Purkinje cells. mol = molecular,
p = Purkinje, gr = granular cell layers. Scale bars: (A, C, F) 200 lm;
(B, D, G, H) 100 lm; (E) 50 lm.
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sion of transgene aldolase C, we used b-gal immunohistochem-
istry in brain sections from the mice carrying the complete or
partially deleted promoter region of the human gene fused to
the b-gal reporter gene. b-gal immunostaining driven by the
pAldC2500-LacZ construct was restricted to the same CA3
hippocampal region that expressed the endogenous aldolase
C (Figs. 4A and B). A higher magniﬁcation shows that b-gal
expression was localized in the cytoplasm of these cells (Figs.
4C–F). Similar results were observed in C-35, C-38 and C-40
founders obtained with the pAldC2500*-LacZ construct that
lacked element D, indicating that the binding of NGFI-B to
this element is not involved in b-gal expression in the hippo-
campus in vivo (data not shown). b-gal was not evident in hip-
pocampus sections from D-37, D-40 and D-42 mice that carry
a large deletion in the distal region not involving element D
(pAldC1500-LacZ plasmid) (Fig. 4G); this is more evident at
higher magniﬁcation (Figs. 4H and I). The results of these
experiments indicate that b-gal expression in the hippocampus
is driven by upstream elements located upstream from element
D.
We next measured endogenous aldolase C messenger
expression on sagittal cerebellar sections of adult mouse brain
using the same speciﬁc riboprobe we used for hippocampus
sections. Fig. 5A shows the result of one experiment showing
groups of aldolase C-positive Purkinje cells alternating to
groups of aldolase C-negative Purkinje cells. The alternating
positive-negative Purkinje cells and the cytoplasmic location
of the messenger are more evident at higher magniﬁcation
(Fig. 5B).
To identify the human aldolase C gene region that contains
the elements suﬃcient to direct b-gal expression in the Purkinje
cells of transgenic mice, we evaluated anti-b-gal antibody
immunostaining in diﬀerent cerebellar sections from the same
transgenic mice analyzed for immunostaining in hippocampus
regions. Immunoreactivity was intense in the Purkinje cell
layer of mice carrying the pAldC2500-LacZ plasmid, which
contains the entire promoter region (Fig. 5C). The pattern of
b-gal expression in the Purkinje cell layer is similar to the
stripe-like pattern of the endogenous aldolase C mRNA found
by in situ hybridization (compare Figs. 5A and C). b-gal
expression was localized in the cytoplasm of stained Purkinje
cells (see higher magniﬁcation in Figs. 5D and E). Similar re-
sults were obtained with cerebellar sections from the transgenic
mice obtained with the pAldC2500*-LacZ construct in which
element D was deleted (data not shown).
Analysis of cerebellar sections from the same three
pAldC1500-LacZ founders (used to detect immunostaining in
the hippocampus) showed low b-gal immunoreactivity in the
Purkinje cell layer (Fig. 5F), as indicated by the longer expo-
sure time required to develop the speciﬁc signal (see Section
2). This result is in agreement with the reduced AldC-LacZ
messenger expression in the brains of adult transgenic founders
obtained with pAldC1500-LacZ (see Fig. 3, black bar). It also
reinforces in vitro [14,15] and in vivo [10–13] results obtained
with human and rat promoter sequences.
To evaluate whether the processing procedure damaged the
cerebellar slices, we stained cerebellar sections adjacent to
those shown in Figs. 5C–E and in Figs. 5F and G with anti-cal-
bindin antibody, which is a speciﬁc Purkinje cell marker. The
protein was distributed throughout the Purkinje cell layer indi-
cating that the layer was not damaged during processing (Fig.5H). This result also conﬁrms the stripe-like distribution of
aldolase C messenger in the Purkinje cell layer and demon-
strates that 200 bp of the human aldolase C gene promoter re-
gion contains all the elements necessary to direct striped
expression of aldolase C messenger in this layer (Figs. 5F
and G).
To verify that the b-gal-positive cells were neurons and not
glial cells, we examined transgenic brains using immunohisto-
chemistry and anti-GFAP antibodies. Sagittal cerebellar
342 P. Buono et al. / FEBS Letters 578 (2004) 337–344sections from an adult B-18 pAldC2500-LacZ mouse showed
speciﬁc immunoreactivity in glial cells (Figs. 6A and B); this
reactivity was absent from Purkinje cells expressing this trans-
gene (Fig. 6C). Anti-GFAP immunohistochemistry of sagittal
sections from hippocampus of the same pAldC2500-LacZ
mouse conﬁrmed speciﬁc immunoreactivity only in glial cells
(Figs. 6D–F); there was no immunoreactivity in pyramidal
CA3 neurons (Fig. 6D, rectangle) that express pAldC2500-
LacZ and pAldC2500*-LacZ transgenic constructs.4. Discussion
Notwithstanding numerous studies focusing on aldolase C
in mammals [10–12,29], the human gene promoter region gov-
erning brain- and cell-speciﬁc aldolase C expression is not
known. Our study conducted with three transgenic mice car-
rying the complete promoter region and a short and a long
deletion in the distal promoter region, respectively, shows that
diverse human aldolase C gene promoter regions are required
to direct speciﬁc LacZ expression in diﬀerent brain areas of
these animals. Our investigation of the hippocampus shows
that aldolase C is expressed exclusively in the pyramidal
CA3 neurons, and that its expression is driven by the distal
promoter region (200/1200 bp) of the human gene. This
region shares a sequence homology of about 52% with the
mouse and rat genes. A CAAT motif and an AT-rich region
spanning from 669 to 735 bp in the human promoter are
identical with the rat and mouse sequences [12]. In the rat
gene, the AT-rich sequences in the fragment located 800
bp from the transcription start site bind POU proteins
[12,13]. It has been suggested that the binding of these pro-
teins to the rat promoter gene results in brain-speciﬁc cis-act-
ing elements that direct the neuronal expression of this gene
[12]. Hence, it is not inconceivable that the aldolase C expres-
sion in CA3 hippocampal neurons in man observed in our
study may be driven by a modular structure constituted byFig. 6. GFAP-immunostaining on cerebellar and hippocampal paraﬃn sagi
matter of cerebellum is evident; (B and C) higher magniﬁcations of the boxe
layer. (D) Scattered GFAP-labeling is evident in hippocampus glial cells; (E
magniﬁcations; note the absence of immunostaining in CA3 pyramidal cells. A
p = Purkinje, gr = granular cell layers, DG = dentate gyrus, CA3 = hippoca
100 lm.an AT-rich motif in the human promoter distal region and
cis-acting elements in the promoter proximal region.
Here, we also demonstrate that a fragment of the human
gene sequence (1190 bp) that lacks element D was able to drive
high brain-speciﬁc aldolase C expression in transgenic mice.
This fragment is much shorter than the rat 6000- and 5500-
bp promoter sequences used by Arai et al. [10] and by Skala
et al. [12], respectively. Therefore, we have narrowed-down
the region within which to search for the cis-element responsi-
ble for high aldolase C expression and its localization in hippo-
campal CA3 neurons. Our data also suggest that the human-
speciﬁc element D is not essential for high aldolase expression
in brain when the fragment of about 1200 bp is present,
whereas it is essential when a much shorter segment (164 bp)
[15] is allowed to direct the transcription of the human aldolase
C gene. The discrepancy between b-gal activity detected by his-
tochemical staining and b-gal expression detected with North-
ern blotting is due to the diﬀerent sensitivity of the two
techniques. In fact, b-gal activity reﬂects the promoter activity
used to produce active b-gal protein molecules. The b-gal
expression of pAldC1500-LacZ in transgenic mice brain is
one-half that of pAldC2500-LacZ expression and results in a
very low number of b-gal molecules. This is conﬁrmed by
the fact that it takes twice as long for anti-b-gal immunostain-
ing to develop in pAldC1500-LacZ mice. Furthermore, the dis-
crepancy between X-gal histochemical staining and anti-b-gal
immunostaining detection have been yet reported [30].
Although the intriguing ‘‘on/oﬀ’’ pattern of aldolase C
expression in the Purkinje cell layer was ﬁrst reported over a
decade ago [17], the gene region governing this pattern in the
human gene was not known. Here we demonstrate that ele-
ments in the proximal promoter sequence (200 bp) of the hu-
man aldolase C gene are able to drive the striped expression of
the gene in Purkinje cells. We may infer that the stripe-like
expression of the aldolase C gene in Purkinje cells is due to
the presence in the proximal region and/or in the ﬁrst intron
of the human gene of a binding-site of a positive or negativettal sections of adult mice. (A) Intense immunoreactivity in the white
d area indicated in A show the absence of labeling in the Purkinje cell
and F) the area outlined by the box is reported in E and F at higher
ll the sections were counterstained with hematoxylin. mol = molecular,
mpal subregion. Scale bars: (A, D) 1000 lm; (B, E) 200 lm; (C, F)
P. Buono et al. / FEBS Letters 578 (2004) 337–344 343element that would switch aldolase C expression on/oﬀ. Alter-
natively, the restricted expression of this gene in groups of Pur-
kinje cells could be due to post-transcriptional events.
Interestingly, the stripe-like expression of aldolase C that we
identiﬁed in Purkinje cells exactly matches that of the cyclin-
dependent kinase 5 activator, protein p39, identiﬁed in mouse
cerebellum [31]; however, we found no sequence homology be-
tween human aldolase C and p39 promoters using the bioin-
formatic program EMBOSS TFSCAN. Like aldolase C, also
the expression of the GABAB metabotropic receptor variant
1b in the rat hippocampus is restricted to the CA3 neurons
[32]. Very recently, it has been reported that the expression
in the hippocampus of the GABAB R1b gene is regulated by
cAMP through a canonical CREB-binding site and by up-
stream stimulatory factor 1 (USF1) that overlaps the CREB
site in the promoter [33]. We found a sequence homology of
about 35% between the two promoters using the mVista bioin-
formatic program. Interestingly, the distal promoter region of
the human aldolase C gene carries a canonical USF1-binding
site just upstream from the NGFI-B binding site (228/233
bp). Furthermore, we recently observed that the binding of
USF1 to the promoter region of the aldolase C gene is in-
volved, together with NGFI-B binding, in the transcriptional
regulation of the aldolase C gene by NGF in PC12 cells (per-
sonal observation).
In conclusion, this study shows that the 1200-bp human
aldolase C gene promoter region contains all the elements re-
quired to drive speciﬁc LacZ expression in hippocampal CA3
neurons and its stripe-like expression in Purkinje cells. It also
provides the groundwork for studies to identify the transcrip-
tional factors responsible for aldolase C expression in the CA3
hippocampal neurons as well as the protein factors involved in
the stripe-like expression of this gene in Purkinje cells. Lastly,
it is tempting to infer that, besides its glycolytic function, hu-
man aldolase C plays another brain-speciﬁc role in cells like
the CA3 neurons and in alternate clusters of Purkinje cells.Acknowledgements: This work was supported by grants from MURST
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